Position in GILD
as of Jun 30, 2026
· filed Jul 9, 2026
Position Value
$2,096,612
-$236,999 QoQ
Shares Held
16,595
-0.9% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.95%
of 13F equity value
Holder Rank
#817
of 2,266 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Lantz Financial LLC holds $16,892,877 across 12 Drug Manufacturers - General names. GILD ranks #4 (12.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
12,860 | $3,266,054 | |
| 2 | LLY |
ELI LILLY & Co
|
2,003 | $2,402,458 | |
| 3 | MRK |
Merck & Co., Inc.
|
17,221 | $2,212,898 | |
| 4 | GILD |
Gilead Sciences, Inc.
This page
|
16,595 | $2,096,612 | |
| 5 | ABBV |
AbbVie Inc.
|
8,202 | $2,063,951 | |
| 6 | NVS |
Novartis AG
|
7,596 | $1,190,445 | |
| 7 | PFE |
Pfizer Inc
|
46,747 | $1,125,667 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
12,833 | $739,437 |
All Filings in GILD
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,096,612 | 16,595 | Shares | Sole | 2026-07-09 | |
| 2026-03-31 | $2,333,611 | 16,744 | Shares | Sole | 2026-04-09 | |
| 2025-12-31 | $2,292,414 | 18,677 | Shares | Sole | 2026-01-14 | |
| 2025-09-30 | $2,272,503 | 20,473 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $2,326,717 | 20,986 | Shares | Sole | 2025-07-11 | |
| 2025-03-31 | $2,491,207 | 22,233 | Shares | Sole | 2025-04-08 | |
| 2024-12-31 | $2,364,672 | 25,600 | Shares | Sole | 2025-01-21 | |
| 2024-09-30 | $2,164,245 | 25,814 | Shares | Sole | 2024-10-15 | |
| 2024-06-30 | $1,709,761 | 24,920 | Shares | Sole | 2024-08-07 | |
| 2024-03-31 | $1,763,860 | 24,080 | Shares | Sole | 2024-04-10 | |
| 2023-12-31 | $1,831,636 | 22,610 | Shares | Sole | 2024-01-12 | |
| 2023-09-30 | $1,641,560 | 21,905 | Shares | Sole | 2023-10-20 | |
| 2023-06-30 | $1,705,019 | 22,123 | Shares | Sole | 2023-07-12 | |
| 2023-03-31 | $1,918,847 | 23,127 | Shares | Sole | 2023-04-10 | |
| 2022-12-31 | $2,218,192 | 25,838 | Shares | Sole | 2023-01-23 | |
| 2022-09-30 | $1,637,252 | 26,540 | Shares | Sole | 2022-10-17 | |
| 2022-06-30 | $1,626,839 | 26,320 | Shares | Sole | 2022-07-29 | |
| 2022-03-31 | $1,538,090 | 25,872 | Shares | Sole | 2022-05-05 | |
| 2021-12-31 | $1,703,648 | 23,463 | Shares | Sole | 2022-01-19 | |
| 2021-09-30 | $1,572,882 | 22,518 | Shares | Sole | 2021-10-14 | |
| 2021-06-30 | $1,513,473 | 21,979 | Shares | Sole | 2021-07-16 | |
| 2021-03-31 | $1,374,873 | 21,273 | Shares | Sole | 2021-04-19 | |
| 2020-12-31 | $1,194,504 | 20,503 | Shares | Sole | 2021-01-19 | |
| 2020-09-30 | $1,270,940 | 20,113 | Shares | Sole | 2020-10-09 | |
| 2020-06-30 | $1,482,402 | 19,267 | Shares | Sole | 2020-07-22 | |
| 2020-03-31 | $1,635,524 | 21,877 | Shares | Sole | 2020-04-10 | |
| No filing history on record for this holder in this stock. | ||||||